Mark R. Mizee

2.1k total citations
17 papers, 1.3k citations indexed

About

Mark R. Mizee is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark R. Mizee has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Mark R. Mizee's work include Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Barrier Structure and Function Studies (4 papers) and Multiple Sclerosis Research Studies (4 papers). Mark R. Mizee is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Barrier Structure and Function Studies (4 papers) and Multiple Sclerosis Research Studies (4 papers). Mark R. Mizee collaborates with scholars based in Netherlands, Germany and United States. Mark R. Mizee's co-authors include Helga E. de Vries, Bert van het Hof, Arie Reijerkerk, Inge Huitinga, Jörg Hamann, Jack van Horssen, Marlijn van der Poel, Joost Drexhage, Gijs Kooij and Cheng‐Chih Hsiao and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Mark R. Mizee

15 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Mizee Netherlands 13 773 390 329 230 173 17 1.3k
Elena Ambrosini Italy 20 547 0.7× 603 1.5× 365 1.1× 171 0.7× 128 0.7× 35 1.5k
Martina Moeton Netherlands 16 402 0.5× 462 1.2× 260 0.8× 292 1.3× 123 0.7× 19 1.2k
Khalil S. Rawji Canada 18 779 1.0× 521 1.3× 401 1.2× 197 0.9× 358 2.1× 26 1.7k
Anna Michel Germany 9 717 0.9× 243 0.6× 443 1.3× 153 0.7× 73 0.4× 30 1.1k
DeRen Huang United States 8 1.0k 1.4× 253 0.6× 609 1.9× 219 1.0× 95 0.5× 8 1.6k
John N. Mariani United States 13 569 0.7× 508 1.3× 114 0.3× 167 0.7× 101 0.6× 21 1.3k
Anne C. Cotleur United States 8 672 0.9× 174 0.4× 488 1.5× 289 1.3× 293 1.7× 11 1.1k
Maria Teresa Cencioni Italy 22 307 0.4× 469 1.2× 400 1.2× 193 0.8× 435 2.5× 32 1.5k
Luokun Xie United States 14 483 0.6× 313 0.8× 290 0.9× 169 0.7× 49 0.3× 19 1.1k
Robert Glumm Germany 10 258 0.3× 319 0.8× 232 0.7× 157 0.7× 247 1.4× 14 994

Countries citing papers authored by Mark R. Mizee

Since Specialization
Citations

This map shows the geographic impact of Mark R. Mizee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Mizee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Mizee more than expected).

Fields of papers citing papers by Mark R. Mizee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Mizee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Mizee. The network helps show where Mark R. Mizee may publish in the future.

Co-authorship network of co-authors of Mark R. Mizee

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Mizee. A scholar is included among the top collaborators of Mark R. Mizee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Mizee. Mark R. Mizee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bink, Diewertje I., Katja Ritz, Claire Mackaaij, et al.. (2025). Lack of intracranial atherosclerosis in various atherosclerotic mouse models. PubMed. 7(1).
2.
Mizee, Mark R., et al.. (2024). Reporting Psychiatric Disease Characteristics in Post-Mortem- and Biological Research. SHILAP Revista de lepidopterología. 19. 2318880536–2318880536. 2 indexed citations
3.
Mizee, Mark R., Jackelien van Scheppingen, Matthew R. J. Mason, et al.. (2023). Microglia Transcriptional Profiling in Major Depressive Disorder Shows Inhibition of Cortical Gray Matter Microglia. Biological Psychiatry. 94(8). 619–629. 33 indexed citations
5.
Böttcher, Chotima, Marlijn van der Poel, Camila Fernández‐Zapata, et al.. (2020). Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis. Acta Neuropathologica Communications. 8(1). 136–136. 44 indexed citations
6.
Poel, Marlijn van der, Thomas Ulas, Mark R. Mizee, et al.. (2019). Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes. Nature Communications. 10(1). 1139–1139. 219 indexed citations
7.
Fransen, Nina L., Joost Smolders, Mark R. Mizee, et al.. (2019). Post‐mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathology. 30(1). 106–119. 23 indexed citations
8.
Mizee, Mark R., Marlijn van der Poel, & Inge Huitinga. (2018). Purification of cells from fresh human brain tissue: primary human glial cells. Handbook of clinical neurology. 150. 273–283. 6 indexed citations
9.
Mizee, Mark R., Suzanne S. M. Miedema, Marlijn van der Poel, et al.. (2017). Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables. Acta Neuropathologica Communications. 5(1). 16–16. 80 indexed citations
10.
Broux, Bieke, Mark R. Mizee, Marjan Vanheusden, et al.. (2015). IL-15 Amplifies the Pathogenic Properties of CD4+CD28− T Cells in Multiple Sclerosis. The Journal of Immunology. 194(5). 2099–2109. 60 indexed citations
11.
Pinheiro, Melissa A Lopes, Gijs Kooij, Mark R. Mizee, et al.. (2015). Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(3). 461–471. 202 indexed citations
12.
Mizee, Mark R., Philip G. Nijland, Susanne M. A. van der Pol, et al.. (2014). Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function in multiple sclerosis. Acta Neuropathologica. 128(5). 691–703. 100 indexed citations
13.
Nijland, Philip G., Iliana Michailidou, Maarten E. Witte, et al.. (2014). Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions. Glia. 62(7). 1125–1141. 97 indexed citations
14.
Mizee, Mark R., Kim Lakeman, Bert van het Hof, et al.. (2013). Retinoic Acid Induces Blood–Brain Barrier Development. Journal of Neuroscience. 33(4). 1660–1671. 154 indexed citations
15.
Mizee, Mark R., et al.. (2013). Blood-brain barrier regulation. Tissue Barriers. 1(5). e26882–e26882. 21 indexed citations
16.
Kamphuis, Willem, Jinte Middeldorp, Lieneke Kooijman, et al.. (2013). Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiology of Aging. 35(3). 492–510. 194 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026